Literature DB >> 16984373

Development of an orthotopic transplantation model in nude mice that simulates the clinical features of human lung cancer.

Yun Kang1, Motoko Omura, Akiko Suzuki, Takashi Oka, Yoshihiro Nakagami, Chao Cheng, Yoji Nagashima, Tomio Inoue.   

Abstract

The objective of the present study was to establish an orthotopic tumor transplantation model in nude mice that closely resembles the clinical features of human lung cancer. The human lung adenocarcinoma A549 cell line and the squamous cell carcinoma SQ5 cell line were used. Tumor cells suspended in serum-free medium were injected directly into the main bronchi of anesthetized female Balb/c athymic nude mice (7-9 weeks old) with or without simultaneous administration of 0.01 M ethylenediaminetetracetic acid (EDTA). In some experiments, lung carcinoma cells harvested from tumors transplanted subcutaneously were recultured and used for intratracheal implantation. Tumor nodules that formed in the lung were counted and confirmed by histological examination. Administration of A549 cells with EDTA resulted in a 70% engraftment rate (n = 10). Recultured A549 cells without and with EDTA resulted in 20% (n = 5) and 80% (n = 5) engraftment rates, respectively. Administration of SQ5 cells without or with EDTA formed 50% (n = 4) and 67% (n = 6) engraftment rates, respectively. Recultured SQ5 cells with EDTA further increased the engraftment rate to 100% (n = 6). Multiple tumors formed mainly in the left lung and the upper lobe of the right lung. Simultaneous administration of EDTA resulted in greater numbers of tumor nodules in the lung. Histological findings revealed that A549 tumor nodules were distributed primarily in alveoli. The SQ5 solid tumors invaded bronchioles and occupied the alveoli. This reproducible orthotopic transplantation model produced tumor growth that simulated the clinical features of human lung cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984373     DOI: 10.1111/j.1349-7006.2006.00276.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  10 in total

1.  The airways, a novel route for delivering monoclonal antibodies to treat lung tumors.

Authors:  Agnès Maillet; Laurent Guilleminault; Etienne Lemarié; Stéphanie Lerondel; Nicolas Azzopardi; Jérôme Montharu; Nicolas Congy-Jolivet; Pascale Reverdiau; Brigitte Legrain; Christelle Parent; Dominique-Henri Douvin; José Hureaux; Yves Courty; Michèle De Monte; Patrice Diot; Gilles Paintaud; Alain Le Pape; Hervé Watier; Nathalie Heuzé-Vourc'h
Journal:  Pharm Res       Date:  2011-04-14       Impact factor: 4.200

2.  Ablative versus fractionated radiation therapy: a controversial role in cancer invasion and metastasis.

Authors:  A Oweida; B Abdulkarim
Journal:  Oncogene       Date:  2016-04-25       Impact factor: 9.867

3.  Proliferation of human lung cancer in an orthotopic transplantation mouse model.

Authors:  Yun Kang; Motoko Omura; Akiko Suzuki; Chumpol Theeraladanon; Takashi Oka; Yoshihiro Nakagami; Atsushi Suzuki; Yoji Nagashima; Tomio Inoue
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

Review 4.  Lung cancer stem cells and low-intensity laser irradiation: a potential future therapy?

Authors:  Anine M Crous; Heidi Abrahamse
Journal:  Stem Cell Res Ther       Date:  2013       Impact factor: 6.832

5.  An orthotopic mouse model of small cell lung cancer reflects the clinical course in patients.

Authors:  Sanaz Taromi; Gian Kayser; Dominik von Elverfeldt; Wilfried Reichardt; Friederike Braun; Wolfgang A Weber; Robert Zeiser; Meike Burger
Journal:  Clin Exp Metastasis       Date:  2016-07-06       Impact factor: 5.150

6.  Establishment of an orthotopic lung cancer model in nude mice and its evaluation by spiral CT.

Authors:  Xiang Liu; Jun Liu; Yubao Guan; Huiling Li; Liyan Huang; Hailing Tang; Jianxing He
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

7.  Effective Rat Lung Tumor Model for Stereotactic Body Radiation Therapy.

Authors:  Zhang Zhang; Michelle Wodzak; Olivier Belzile; Heling Zhou; Brock Sishc; Hao Yan; Strahinja Stojadinovic; Ralph P Mason; Rolf A Brekken; Rajiv Chopra; Michael D Story; Robert Timmerman; Debabrata Saha
Journal:  Radiat Res       Date:  2016-05-25       Impact factor: 2.841

8.  Development of a novel orthotopic non-small cell lung cancer model and therapeutic benefit of 2'-(2-bromohexadecanoyl)-docetaxel conjugate nanoparticles.

Authors:  Lei Peng; Lan Feng; Hong Yuan; S Rahima Benhabbour; Russell J Mumper
Journal:  Nanomedicine       Date:  2014-04-04       Impact factor: 5.307

9.  Bioluminescent orthotopic mouse models of human localized non-small cell lung cancer: feasibility and identification of circulating tumour cells.

Authors:  Pierre Mordant; Yohann Loriot; Benoit Lahon; Yves Castier; Guy Lesèche; Jean-Charles Soria; Marie-Catherine Vozenin; Charles Decraene; Eric Deutsch
Journal:  PLoS One       Date:  2011-10-11       Impact factor: 3.240

10.  Development of human alveolar epithelial cell models to study distal lung biology and disease.

Authors:  Evelyn Tran; Tuo Shi; Xiuwen Li; Adnan Y Chowdhury; Du Jiang; Yixin Liu; Hongjun Wang; Chunli Yan; William D Wallace; Rong Lu; Amy L Ryan; Crystal N Marconett; Beiyun Zhou; Zea Borok; Ite A Offringa
Journal:  iScience       Date:  2022-01-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.